High Dose Chemotherapy Followed By PBSC Rescue for HD
Completed · Not applicable
Conditions studied: Hodgkin Disease
In brief
To evaluate the role of high dose chemotherapy with autologous hematopoietic cell transplantation in the treatment of Hodgkin's Disease.
Key facts
- Study ID
- NCT00186251
- Run by
- Stanford University
- People needed
- 200
- Starts
- 1998-03-01
- Expected to finish
- 2005-07-01
- Last updated by the study team
- 2012-11-12
Who can join
Age: 0 and older, up to 70. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Stanford University School of Medicine — Stanford, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.